Candida dubliniensis fungemia in a solid organ transplant patient: Case report and review of the literature

Medical Mycology

Volumn 39, Issue 6, 2001, Pages 483-485

  Gottlieb, G S ^a   Limaye, A P ^a   Chen, Y C ^a   Van Voorhis, W C ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Candidemia; Fungal; Transplantation; Yeast

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; FLUCONAZOLE; PYRROLE DERIVATIVE; VANCOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE KIDNEY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CASE REPORT; DIAGNOSTIC ACCURACY; DOSE RESPONSE; FEMALE; FUNGEMIA; FUNGUS IDENTIFICATION; HEPATITIS; HUMAN; IMMUNE DEFICIENCY; LIVER DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; NONHUMAN; POPULATION; STAPHYLOCOCCUS; YEAST;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; FUNGI; STAPHYLOCOCCUS;

EID: 0035666721     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/mmy.39.6.483.485     Document Type: Article

References (12)

1. Sullivan DJ, Westemeng TJ, Haynes KA, Benne DE, Coleman DC. Candida ditbliniensis sp, nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995; 141: 1507-1521.
2. Coleman DC. Sullivan DJ, Bennett DE, Moran GP, Barry HJ, Shanley DB. Candidiasis: the emergence of a novel species. Candida ditbliniensis. AIDS 1997; 11: 557-567.
3. Sullivan, DJ, Coleman, DC. Candida dubliniensis: characteristics and identification. J Clin Microbiol 1998; 36: 329-334.
4. Sullivan D, Haynes K, Bille J, et al. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J din Microbiol 1997; 35: 960-964.
5. Jabra-Rizk MA, Baqui AA. Kelley JI, Falkler WA Jr, Merz WG, Meiller TF. Identification of Candida dubliniensis: in a prospective study of patients in the United States. J Clin Microbiol 1999; 37: 321-326.
6. Moran GP. Sullivan DJ, Henman MC, et al. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HlV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother 1997; 41: 617-623.
7. Chen Y-C. Eisner JD, Kattar MM, et al. Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genes. J Clin Microbiol 2000; 38: 2302-2310.
8. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. Wayne (PA): The Committee; 1997.
9. Meis JF. Ruhnke M. De Pauw BE, Odds FC, Siegert W, Verweij PE. Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emerg Infect Dis 1999; 5: 150-153.
10. Brandt ME, Harrison LH. Pass M, et al. Candida dubliniensis: fungemia: the first four cases in North America. Emerg Infect Dis 2000; 6: 46-49.
11. Pfaller MA, Messer SA, Gee S, et a!. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J Clin Microbiol 1999; 37: 870-872.
12. Quindos G, Carrillo-Munoz AJ, Arevalo MP, et al. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents. Chemotherapy 2000; 46: 395-401.